1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: January 18 -24, 2026
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: January 18 -24, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

Event Date: 01/22/2026
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: BRIAN FAHEY; 
Non FDA Participant/Group: Representative Michael Lawler (R-NY)

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs

No Significant Event

Official Name: Sean R. Keveney, Chief Counsel

No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods

Event Date: 01/22/2026
Location: College Park, MD
Subject: Food Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: FDA Foods Coalition representatives

Event Date: 01/23/2026
Location: Virtual
Subject: Infant Formula 
FDA Participant/Group: ROBIN MCKINNON; DONALD PRATER; REBECCA BUCKNER; ELIZABETH SCHULZ; 
Non FDA Participant/Group: Kim Corbin (Corbin Strategies); Laura Modi (Bobbie Baby);

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations

No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

Event Date: 01/20/2026
Location: Virtual
Subject: Nonprescription Drug Product With an Additional Condition for Nonprescription Use (ACNU) Rule
FDA Participant/Group: LUKE HALL; KARIM MIKHAIL; 
Non FDA Participant/Group: Jim Parker, Mary Alice Lawless (BXA Solutions);

Event Date: 01/21/2026
Location: Silver Spring, MD
Subject: Removal of Oral Phenylephrine (PE) From OTC Cough and Cold Products
FDA Participant/Group: MARTA SOKOLOWSKA; LUKE HALL; 
Non FDA Participant/Group: Proctor and Gamble representatives

Event Date: 01/22/2026
Location: Virtual
Subject: Device Free Epinephrine Film
FDA Participant/Group: KARIM MIKHAIL; LUKE HALL; 
Non FDA Participant/Group: Aquestive and Bracewell representatives

Event Date: 01/22/2026
Location: Virtual
Subject: Advancing Legislative and Regulatory Framework for the Emerging Hemp Industry 
FDA Participant/Group: N/A
Non FDA Participant/Group: Andrew Bish (Bish Enterprises); Morgan Tweet (IND Hemp); Graham Rigby (American Herbal Products Association (AHPA)); Geoff Whaling (National Hemp Association);

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

Event Date: 01/23/2026
Location: Silver Spring, MD
Subject: Association of Food and Drug Officials (AFDO) Board Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Association of Food and Drug Officials (AFDO) representatives

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 01/23/2026
Location: Arlington, VA
Subject: Advanced Research Projects Agency for Health's ADVOCATE Program Launch Event; Panelist: HHS Roundtable
FDA Participant/Group: N/A
Non FDA Participant/Group: Tech sector, academia, non-profit organizations, and small businesses

Official Name: Tracy Beth Høeg M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine

No Significant Event

Back to Top